Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.36 - $9.25 $1,836 - $47,175
-5,100 Reduced 99.8%
10 $0
Q2 2022

Oct 27, 2022

SELL
$0.38 - $1.05 $46 - $129
-123 Reduced 2.35%
5,110 $2,000
Q2 2022

Aug 15, 2022

SELL
$0.38 - $1.05 $46 - $129
-123 Reduced 2.35%
5,110 $2,000
Q1 2022

Oct 27, 2022

BUY
$0.52 - $1.3 $63 - $159
123 Added 2.41%
5,233 $4,000
Q1 2022

May 13, 2022

BUY
$0.52 - $1.3 $2,663 - $6,658
5,122 Added 4614.41%
5,233 $4,000
Q4 2021

Feb 14, 2022

BUY
$0.66 - $1.18 $0 - $1
1 Added 0.91%
111 $0
Q3 2021

Nov 15, 2021

BUY
$1.15 - $1.62 $126 - $178
110 New
110 $0

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.02M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.